Ken Reali Appointed to Succeed Tony Bihl as CEO of Bioventus
In January of this year, we announced Tony Bihl’s planned retirement and the search for his replacement. Today we announce, the Bioventus Board of Managers has unanimously appointed Ken Reali, former President and CEO of Clinical Innovations, LLC, to assume the role of CEO of Bioventus. Reali will also become a member of the Bioventus Board and begins work effective April 20, 2020.
Clinical Innovations is a medical device company focused in woman’s healthcare, Ken served as its CEO from June 2015 until its successful sale on February 12, 2020. He started his career at Biomet and worked at Stryker, Smith & Nephew and Baxano Surgical where he held positions of increasing responsibility, including CEO over the past ten years. Reali also worked within the Clinical Therapies business of Smith & Nephew over a decade ago which was later spun out to become Bioventus. He currently serves on the boards of Ossio Integrative Orthopedics, AdvaMed and AdvaMed Accel and is Chairman of the Ethics and Compliance Committee for AdvaMed.
“I am honored to have the opportunity to lead Bioventus,” said Ken. “The Company’s broad product portfolio, global presence and solid growth have it well positioned to serve the needs of patients and physicians. Even more successes lie ahead and I’m excited to work with the talented Bioventus team to drive strong value for all stakeholders.”
Tony Bihl’s last day with Bioventus will be April 30.
“Today I feel great satisfaction with the progress we have made toward achieving our mission and growing Bioventus. We have broadened our product offering, built a talented team, grown revenue and profit each year, and woven together a positive culture focused on the patients we serve,” said Bihl. “I want to thank the Board and my colleagues at this great company and I know Ken Reali will bring new ideas and energy for the next growth phase of Bioventus.”
Ken will move to the Raleigh-Durham area with his wife Kristin and we will have a formal Town Hall to introduce him to all employees the week of April 20th. More details on that meeting will be shared with you in the coming weeks. In the meantime, if you would like to send him an email he may be reached at [email protected].